Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...

Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...

KKR posted fourth-quarter net income growth as lower expenses offset a drop in revenue, and assets under management at the buyout firm grew as it prepared for a potential deal bonanza in the second ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...

KKR Tries Playing the White Knight Against Some Activists The private-equity firm will have a 12% stake in Henry Schein, with an option to buy more. Analysts expect adjusted profit to drop 11% ...

Investing.com -- Investment firm KKR is set to increase its stake in Henry Schein ... and its commitment to delivering shareholder value. In other financial news, Henry Schein has released preliminary ...